Clinical benefits of novel non-nucleoside reverse transcriptase inhibitors: A prospective cohort study.

Shujing MaXiaoxin XieYanhua FuLin GanXiaoyan YangLinghong KongJun LiHai Long

Published in: Immunity, inflammation and disease (2024)

Both regimens showed good virological effectiveness; however, compared with ANV+3TC+TDF, the EFV+3TC+TDF regimen reduced the prevalence of HIV-related symptoms.

Keyphrases

antiretroviral therapy
hiv infected
hiv positive
human immunodeficiency virus
hiv aids
hiv infected patients
randomized controlled trial
hiv testing
systematic review
hepatitis c virus
risk factors
men who have sex with men
sleep quality
south africa
depressive symptoms